For avapritinib, mechanisms of secondary resistance in PDGFRA-mutant GIST involve compound mutations of exons 13, 14, and 15 of PDGFRA with codon 658 and 680 mutations representing a recurrent cause of resistance [59]. Here, PDGFRA is linked to gastrointestinal stromal tumor.